

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sarcomere organization (GO:0045214) | 8.83171152 |
| 2 | cardiac myofibril assembly (GO:0055003) | 8.81419659 |
| 3 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 7.94123138 |
| 4 | myofibril assembly (GO:0030239) | 7.53201129 |
| 5 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 7.45780792 |
| 6 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 7.24389037 |
| 7 | cardiac muscle contraction (GO:0060048) | 6.87974604 |
| 8 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.68434674 |
| 9 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.58411984 |
| 10 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 6.50685076 |
| 11 | cardiac muscle cell development (GO:0055013) | 6.40443134 |
| 12 | regulation of actin filament-based movement (GO:1903115) | 6.39178227 |
| 13 | tricarboxylic acid cycle (GO:0006099) | 6.32477814 |
| 14 | ventricular cardiac muscle cell action potential (GO:0086005) | 6.13872204 |
| 15 | cardiac cell development (GO:0055006) | 5.99448048 |
| 16 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 5.96124065 |
| 17 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 5.83489856 |
| 18 | adult heart development (GO:0007512) | 5.81801313 |
| 19 | actin-myosin filament sliding (GO:0033275) | 5.81482026 |
| 20 | muscle filament sliding (GO:0030049) | 5.81482026 |
| 21 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.73943171 |
| 22 | cardiac muscle tissue morphogenesis (GO:0055008) | 5.70769923 |
| 23 | regulation of relaxation of muscle (GO:1901077) | 5.65572516 |
| 24 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 5.63752965 |
| 25 | heart trabecula formation (GO:0060347) | 5.50885912 |
| 26 | regulation of sarcomere organization (GO:0060297) | 5.49387306 |
| 27 | cardiac muscle hypertrophy (GO:0003300) | 5.47890575 |
| 28 | actomyosin structure organization (GO:0031032) | 5.46786968 |
| 29 | plasma membrane repair (GO:0001778) | 5.46377334 |
| 30 | cell communication involved in cardiac conduction (GO:0086065) | 5.22574037 |
| 31 | striated muscle hypertrophy (GO:0014897) | 5.17149353 |
| 32 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.16446023 |
| 33 | regulation of striated muscle contraction (GO:0006942) | 5.14512714 |
| 34 | regulation of the force of heart contraction (GO:0002026) | 5.10174499 |
| 35 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.08842907 |
| 36 | regulation of membrane repolarization (GO:0060306) | 5.07535671 |
| 37 | muscle tissue morphogenesis (GO:0060415) | 5.04804783 |
| 38 | striated muscle contraction (GO:0006941) | 4.98645004 |
| 39 | regulation of response to osmotic stress (GO:0047484) | 4.94939154 |
| 40 | regulation of cell communication by electrical coupling (GO:0010649) | 4.90231728 |
| 41 | cell communication by electrical coupling (GO:0010644) | 4.89573836 |
| 42 | heart process (GO:0003015) | 4.87887059 |
| 43 | heart contraction (GO:0060047) | 4.87887059 |
| 44 | regulation of cardiac muscle cell contraction (GO:0086004) | 4.81811280 |
| 45 | regulation of skeletal muscle contraction (GO:0014819) | 4.77135675 |
| 46 | actin-mediated cell contraction (GO:0070252) | 4.76142677 |
| 47 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.74934668 |
| 48 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.74069406 |
| 49 | carnitine shuttle (GO:0006853) | 4.73060027 |
| 50 | regulation of cardiac muscle contraction (GO:0055117) | 4.62437349 |
| 51 | muscle hypertrophy (GO:0014896) | 4.55263423 |
| 52 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 4.44673333 |
| 53 | ATP synthesis coupled proton transport (GO:0015986) | 4.43584808 |
| 54 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.43584808 |
| 55 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.38929005 |
| 56 | regulation of coenzyme metabolic process (GO:0051196) | 4.34810820 |
| 57 | regulation of cofactor metabolic process (GO:0051193) | 4.34810820 |
| 58 | complement activation, alternative pathway (GO:0006957) | 4.33300661 |
| 59 | negative regulation of potassium ion transport (GO:0043267) | 4.32986674 |
| 60 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.30262535 |
| 61 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 4.29387530 |
| 62 | hemoglobin metabolic process (GO:0020027) | 4.29146349 |
| 63 | relaxation of cardiac muscle (GO:0055119) | 4.27169886 |
| 64 | respiratory electron transport chain (GO:0022904) | 4.25782890 |
| 65 | regulation of heart rate (GO:0002027) | 4.25342813 |
| 66 | cardiac muscle cell action potential (GO:0086001) | 4.23796954 |
| 67 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 4.21312268 |
| 68 | regulation of cardioblast differentiation (GO:0051890) | 4.18631205 |
| 69 | electron transport chain (GO:0022900) | 4.12845921 |
| 70 | fatty acid transmembrane transport (GO:1902001) | 4.04210131 |
| 71 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 4.02129349 |
| 72 | negative regulation of protein localization to cell surface (GO:2000009) | 4.02067332 |
| 73 | oxidative phosphorylation (GO:0006119) | 4.00917938 |
| 74 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.99006610 |
| 75 | muscle hypertrophy in response to stress (GO:0003299) | 3.99006610 |
| 76 | cardiac muscle adaptation (GO:0014887) | 3.99006610 |
| 77 | ventricular cardiac muscle cell development (GO:0055015) | 3.94210836 |
| 78 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.93509574 |
| 79 | protein carboxylation (GO:0018214) | 3.93509574 |
| 80 | potassium ion export (GO:0071435) | 3.90147338 |
| 81 | * regulation of heart contraction (GO:0008016) | 3.89679097 |
| 82 | cardiac conduction (GO:0061337) | 3.89483728 |
| 83 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.85316627 |
| 84 | negative regulation of fibrinolysis (GO:0051918) | 3.84354682 |
| 85 | NADH metabolic process (GO:0006734) | 3.83934474 |
| 86 | regulation of ATPase activity (GO:0043462) | 3.83188225 |
| 87 | regulation of ATP catabolic process (GO:1903289) | 3.83188225 |
| 88 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.82811205 |
| 89 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.80113620 |
| 90 | urea cycle (GO:0000050) | 3.76261782 |
| 91 | urea metabolic process (GO:0019627) | 3.71864023 |
| 92 | regulation of triglyceride catabolic process (GO:0010896) | 3.71220422 |
| 93 | oxygen transport (GO:0015671) | 3.69195686 |
| 94 | negative regulation of cholesterol transport (GO:0032375) | 3.67709074 |
| 95 | negative regulation of sterol transport (GO:0032372) | 3.67709074 |
| 96 | positive regulation of cation channel activity (GO:2001259) | 3.66105407 |
| 97 | 2-oxoglutarate metabolic process (GO:0006103) | 3.59816583 |
| 98 | positive regulation of heart contraction (GO:0045823) | 3.59077092 |
| 99 | activation of MAPKKK activity (GO:0000185) | 3.56139929 |
| 100 | actin filament-based movement (GO:0030048) | 3.56092855 |
| 101 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.56085704 |
| 102 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.56085704 |
| 103 | regulation of fibrinolysis (GO:0051917) | 3.53914398 |
| 104 | regulation of sulfur metabolic process (GO:0042762) | 3.52353847 |
| 105 | positive regulation of heart rate (GO:0010460) | 3.51905779 |
| 106 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.49857150 |
| 107 | detection of calcium ion (GO:0005513) | 3.49546342 |
| 108 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.48629347 |
| 109 | striated muscle cell development (GO:0055002) | 3.48072360 |
| 110 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.47228407 |
| 111 | trabecula formation (GO:0060343) | 3.45847763 |
| 112 | germinal center formation (GO:0002467) | 3.45626563 |
| 113 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.45576023 |
| 114 | carnitine transmembrane transport (GO:1902603) | 3.43964200 |
| 115 | nitrogen cycle metabolic process (GO:0071941) | 3.41571009 |
| 116 | regulation of striated muscle cell apoptotic process (GO:0010662) | 3.36533341 |
| 117 | mannose metabolic process (GO:0006013) | 3.35726238 |
| 118 | embryonic camera-type eye morphogenesis (GO:0048596) | 3.28835389 |
| 119 | negative regulation of lipid transport (GO:0032369) | 3.28329784 |
| 120 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.28006606 |
| 121 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.28006606 |
| 122 | positive regulation of lipid catabolic process (GO:0050996) | 3.27889825 |
| 123 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.23216922 |
| 124 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.18649191 |
| 125 | negative regulation of fatty acid transport (GO:2000192) | 3.17706135 |
| 126 | regulation of hypersensitivity (GO:0002883) | 3.16015798 |
| 127 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.14717640 |
| 128 | receptor recycling (GO:0001881) | 3.11461598 |
| 129 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.08872542 |
| 130 | response to muramyl dipeptide (GO:0032495) | 3.07515038 |
| 131 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.07488963 |
| 132 | phospholipid efflux (GO:0033700) | 3.00295113 |
| 133 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.99702971 |
| 134 | positive regulation of hemostasis (GO:1900048) | 2.95387466 |
| 135 | positive regulation of blood coagulation (GO:0030194) | 2.95387466 |
| 136 | tooth mineralization (GO:0034505) | 2.89909938 |
| 137 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.89728978 |
| 138 | NIK/NF-kappaB signaling (GO:0038061) | 2.84560471 |
| 139 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.81101001 |
| 140 | regulation of female gonad development (GO:2000194) | 2.79661293 |
| 141 | response to methylmercury (GO:0051597) | 2.76039424 |
| 142 | detection of molecule of bacterial origin (GO:0032490) | 2.73268541 |
| 143 | alkaloid metabolic process (GO:0009820) | 2.72935095 |
| 144 | regulation of protein activation cascade (GO:2000257) | 2.72359535 |
| 145 | positive regulation of coagulation (GO:0050820) | 2.68029865 |
| 146 | regulation of complement activation (GO:0030449) | 2.66535753 |
| 147 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.63693173 |
| 148 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.61637047 |
| 149 | detection of external biotic stimulus (GO:0098581) | 2.59730556 |
| 150 | chondroitin sulfate biosynthetic process (GO:0030206) | 2.59004443 |
| 151 | regulation of p38MAPK cascade (GO:1900744) | 2.57298430 |
| 152 | fibrinolysis (GO:0042730) | 2.56781887 |
| 153 | cellular hyperosmotic response (GO:0071474) | 2.55758813 |
| 154 | regulation of fatty acid biosynthetic process (GO:0042304) | 2.55498825 |
| 155 | regulation of leukocyte degranulation (GO:0043300) | 2.55052864 |
| 156 | basement membrane organization (GO:0071711) | 2.54293971 |
| 157 | protein-lipid complex remodeling (GO:0034368) | 2.53495969 |
| 158 | macromolecular complex remodeling (GO:0034367) | 2.53495969 |
| 159 | plasma lipoprotein particle remodeling (GO:0034369) | 2.53495969 |
| 160 | regulation of protein polyubiquitination (GO:1902914) | 2.51530087 |
| 161 | detection of other organism (GO:0098543) | 2.50554046 |
| 162 | positive regulation of phagocytosis (GO:0050766) | 2.49459666 |
| 163 | imidazole-containing compound metabolic process (GO:0052803) | 2.46760756 |
| 164 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.46065730 |
| 165 | negative regulation of type 2 immune response (GO:0002829) | 2.45879443 |
| 166 | UV protection (GO:0009650) | 2.45731959 |
| 167 | embryonic eye morphogenesis (GO:0048048) | 2.44059830 |
| 168 | regulation of plasminogen activation (GO:0010755) | 2.42864535 |
| 169 | opsonization (GO:0008228) | 2.42268369 |
| 170 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.41860503 |
| 171 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.40765315 |
| 172 | L-phenylalanine catabolic process (GO:0006559) | 2.40765315 |
| 173 | glyoxylate metabolic process (GO:0046487) | 2.39876127 |
| 174 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.39703526 |
| 175 | detection of bacterium (GO:0016045) | 2.39026016 |
| 176 | protein activation cascade (GO:0072376) | 2.38616995 |
| 177 | regulation of lipid catabolic process (GO:0050994) | 2.35653574 |
| 178 | macrophage activation involved in immune response (GO:0002281) | 2.35263374 |
| 179 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.34382512 |
| 180 | acute-phase response (GO:0006953) | 2.33550635 |
| 181 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.33370609 |
| 182 | complement activation (GO:0006956) | 2.32701341 |
| 183 | phosphate ion transmembrane transport (GO:0035435) | 2.30918986 |
| 184 | regulation of apoptotic cell clearance (GO:2000425) | 2.30456436 |
| 185 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.30266402 |
| 186 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.30014134 |
| 187 | regulation of humoral immune response (GO:0002920) | 2.29268431 |
| 188 | positive regulation of humoral immune response (GO:0002922) | 2.28612889 |
| 189 | regulation of cholesterol storage (GO:0010885) | 2.27650624 |
| 190 | pinocytosis (GO:0006907) | 2.26595260 |
| 191 | complement activation, classical pathway (GO:0006958) | 2.26379124 |
| 192 | modulation by symbiont of host cellular process (GO:0044068) | 2.25879976 |
| 193 | regulation of mast cell degranulation (GO:0043304) | 2.25313545 |
| 194 | folic acid metabolic process (GO:0046655) | 2.24791554 |
| 195 | definitive hemopoiesis (GO:0060216) | 2.24400043 |
| 196 | regulation of phagocytosis (GO:0050764) | 2.22547706 |
| 197 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.22304654 |
| 198 | L-phenylalanine metabolic process (GO:0006558) | 2.22121665 |
| 199 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.22121665 |
| 200 | modulation by virus of host process (GO:0019054) | 2.22116353 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.09881302 |
| 2 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 5.04007931 |
| 3 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 4.79791306 |
| 4 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.98546888 |
| 5 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.95842350 |
| 6 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 3.91401207 |
| 7 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 3.91401207 |
| 8 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.60492071 |
| 9 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.38143395 |
| 10 | MYC_22102868_ChIP-Seq_BL_Human | 3.35448744 |
| 11 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.28970766 |
| 12 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 3.08535358 |
| 13 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.98991991 |
| 14 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.80642282 |
| 15 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.72967250 |
| 16 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.57022445 |
| 17 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.40333843 |
| 18 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.32328859 |
| 19 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.28322951 |
| 20 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 2.27900130 |
| 21 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.23752159 |
| 22 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.22438455 |
| 23 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.14412414 |
| 24 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.11382238 |
| 25 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.09983395 |
| 26 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 2.09952703 |
| 27 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.04425251 |
| 28 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.96239782 |
| 29 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.91979173 |
| 30 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.90380799 |
| 31 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.90141577 |
| 32 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.88748497 |
| 33 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.88193236 |
| 34 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.85554219 |
| 35 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.77956117 |
| 36 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.76321078 |
| 37 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.75175115 |
| 38 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.73281767 |
| 39 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.66282737 |
| 40 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.64786444 |
| 41 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.64268025 |
| 42 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.61880296 |
| 43 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.60578260 |
| 44 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.57318297 |
| 45 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.56735247 |
| 46 | MAF_26560356_Chip-Seq_TH1_Human | 1.55832520 |
| 47 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.54864948 |
| 48 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.52381919 |
| 49 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.52187801 |
| 50 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.47338024 |
| 51 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.47335267 |
| 52 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.46811133 |
| 53 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.46652907 |
| 54 | UTX_26944678_Chip-Seq_JUKART_Human | 1.44741433 |
| 55 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.43232630 |
| 56 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.38823413 |
| 57 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.38747553 |
| 58 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.37184536 |
| 59 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.35634842 |
| 60 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.34555006 |
| 61 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.34500202 |
| 62 | MAF_26560356_Chip-Seq_TH2_Human | 1.34435510 |
| 63 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.33238156 |
| 64 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.31985805 |
| 65 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.31611385 |
| 66 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.31361344 |
| 67 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.31161225 |
| 68 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.30182345 |
| 69 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.30019856 |
| 70 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.29836906 |
| 71 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.29758344 |
| 72 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.29758344 |
| 73 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29613474 |
| 74 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.28264661 |
| 75 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.24532828 |
| 76 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.23034715 |
| 77 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.22664353 |
| 78 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.22447050 |
| 79 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.21128289 |
| 80 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.21113269 |
| 81 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.21060730 |
| 82 | GATA1_19941826_ChIP-Seq_K562_Human | 1.20674257 |
| 83 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.20417800 |
| 84 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.18120126 |
| 85 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.16124888 |
| 86 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.15350051 |
| 87 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.14504157 |
| 88 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.14499971 |
| 89 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.14409310 |
| 90 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.13026567 |
| 91 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.12805492 |
| 92 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.12774422 |
| 93 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12191469 |
| 94 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.12034495 |
| 95 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.11579163 |
| 96 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.11023304 |
| 97 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.10973723 |
| 98 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.10476505 |
| 99 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.09788988 |
| 100 | * TP63_22573176_ChIP-Seq_HFKS_Human | 1.09331296 |
| 101 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.08451009 |
| 102 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.08163751 |
| 103 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.07346969 |
| 104 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.06984152 |
| 105 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.05200162 |
| 106 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.05129276 |
| 107 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.04339058 |
| 108 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.03810237 |
| 109 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.03579229 |
| 110 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.02783726 |
| 111 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02766068 |
| 112 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.02204913 |
| 113 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.01229105 |
| 114 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.01125008 |
| 115 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.00982350 |
| 116 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.00773572 |
| 117 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.00184466 |
| 118 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.99777454 |
| 119 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.99603868 |
| 120 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.99298958 |
| 121 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.98959294 |
| 122 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.98690713 |
| 123 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.98587325 |
| 124 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.98576535 |
| 125 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.97187748 |
| 126 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95457418 |
| 127 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.94808631 |
| 128 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.94697042 |
| 129 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.94667493 |
| 130 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.94609068 |
| 131 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.94554030 |
| 132 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.94517909 |
| 133 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94515013 |
| 134 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.92612166 |
| 135 | KDM2B_26808549_Chip-Seq_K562_Human | 0.92386412 |
| 136 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.91221359 |
| 137 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.91185183 |
| 138 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.90404505 |
| 139 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.89819511 |
| 140 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.89431161 |
| 141 | SPI1_23127762_ChIP-Seq_K562_Human | 0.88652565 |
| 142 | GATA1_22025678_ChIP-Seq_K562_Human | 0.88203234 |
| 143 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87630102 |
| 144 | P68_20966046_ChIP-Seq_HELA_Human | 0.87562244 |
| 145 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.87241981 |
| 146 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.87058859 |
| 147 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86168963 |
| 148 | GATA2_19941826_ChIP-Seq_K562_Human | 0.85997152 |
| 149 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.85488441 |
| 150 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.85454484 |
| 151 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.83930726 |
| 152 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.82578582 |
| 153 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.81871835 |
| 154 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.81870323 |
| 155 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.81180226 |
| 156 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.80022293 |
| 157 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.79169339 |
| 158 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.78854569 |
| 159 | ATF3_27146783_Chip-Seq_COLON_Human | 0.78430294 |
| 160 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.78331288 |
| 161 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.78184741 |
| 162 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.76159503 |
| 163 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.76110360 |
| 164 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.75086535 |
| 165 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.74737530 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 7.00595607 |
| 2 | MP0004084_abnormal_cardiac_muscle | 6.11368124 |
| 3 | MP0003646_muscle_fatigue | 5.42432985 |
| 4 | MP0004215_abnormal_myocardial_fiber | 5.21506033 |
| 5 | MP0000751_myopathy | 5.11709643 |
| 6 | MP0004036_abnormal_muscle_relaxation | 4.33772044 |
| 7 | MP0005330_cardiomyopathy | 4.04045057 |
| 8 | MP0002139_abnormal_hepatobiliary_system | 3.97762449 |
| 9 | MP0000749_muscle_degeneration | 3.44816702 |
| 10 | MP0002972_abnormal_cardiac_muscle | 3.31319432 |
| 11 | MP0003137_abnormal_impulse_conducting | 3.26112274 |
| 12 | MP0008775_abnormal_heart_ventricle | 3.10748011 |
| 13 | MP0005360_urolithiasis | 3.07859025 |
| 14 | MP0002396_abnormal_hematopoietic_system | 3.04841363 |
| 15 | MP0004087_abnormal_muscle_fiber | 2.94464910 |
| 16 | MP0009840_abnormal_foam_cell | 2.87271654 |
| 17 | MP0005385_cardiovascular_system_phenoty | 2.75244282 |
| 18 | MP0001544_abnormal_cardiovascular_syste | 2.75244282 |
| 19 | MP0005058_abnormal_lysosome_morphology | 2.74019114 |
| 20 | MP0005076_abnormal_cell_differentiation | 2.70392639 |
| 21 | MP0010630_abnormal_cardiac_muscle | 2.66721796 |
| 22 | MP0005620_abnormal_muscle_contractility | 2.64209212 |
| 23 | MP0006138_congestive_heart_failure | 2.62697843 |
| 24 | MP0004484_altered_response_of | 2.60230540 |
| 25 | MP0003191_abnormal_cellular_cholesterol | 2.54792372 |
| 26 | MP0000750_abnormal_muscle_regeneration | 2.50891267 |
| 27 | MP0003828_pulmonary_edema | 2.42299150 |
| 28 | MP0004085_abnormal_heartbeat | 2.38183285 |
| 29 | MP0004130_abnormal_muscle_cell | 2.31529172 |
| 30 | MP0002106_abnormal_muscle_physiology | 2.30883903 |
| 31 | MP0002138_abnormal_hepatobiliary_system | 2.24837884 |
| 32 | MP0003091_abnormal_cell_migration | 2.15223035 |
| 33 | MP0005409_darkened_coat_color | 2.08295387 |
| 34 | MP0002269_muscular_atrophy | 2.06544332 |
| 35 | MP0003436_decreased_susceptibility_to | 2.06408178 |
| 36 | MP0004510_myositis | 1.97355635 |
| 37 | MP0003172_abnormal_lysosome_physiology | 1.95690981 |
| 38 | MP0000685_abnormal_immune_system | 1.95226909 |
| 39 | MP0003221_abnormal_cardiomyocyte_apopto | 1.94595083 |
| 40 | MP0003303_peritoneal_inflammation | 1.90796503 |
| 41 | MP0004381_abnormal_hair_follicle | 1.90333674 |
| 42 | MP0009278_abnormal_bone_marrow | 1.85050128 |
| 43 | MP0005369_muscle_phenotype | 1.84609463 |
| 44 | MP0008875_abnormal_xenobiotic_pharmacok | 1.83647883 |
| 45 | MP0004145_abnormal_muscle_electrophysio | 1.82270193 |
| 46 | MP0005365_abnormal_bile_salt | 1.73150230 |
| 47 | MP0002127_abnormal_cardiovascular_syste | 1.72851819 |
| 48 | MP0001986_abnormal_taste_sensitivity | 1.71421369 |
| 49 | MP0000747_muscle_weakness | 1.71242647 |
| 50 | MP0001545_abnormal_hematopoietic_system | 1.71198808 |
| 51 | MP0005397_hematopoietic_system_phenotyp | 1.71198808 |
| 52 | MP0006036_abnormal_mitochondrial_physio | 1.69616094 |
| 53 | MP0000759_abnormal_skeletal_muscle | 1.69450936 |
| 54 | MP0004233_abnormal_muscle_weight | 1.61672756 |
| 55 | MP0002089_abnormal_postnatal_growth/wei | 1.57163032 |
| 56 | MP0001835_abnormal_antigen_presentation | 1.56039249 |
| 57 | MP0003183_abnormal_peptide_metabolism | 1.52442906 |
| 58 | MP0004858_abnormal_nervous_system | 1.50170897 |
| 59 | MP0002419_abnormal_innate_immunity | 1.44160395 |
| 60 | MP0004808_abnormal_hematopoietic_stem | 1.42892176 |
| 61 | MP0003950_abnormal_plasma_membrane | 1.42467961 |
| 62 | MP0005085_abnormal_gallbladder_physiolo | 1.40252230 |
| 63 | MP0001851_eye_inflammation | 1.38412535 |
| 64 | MP0008260_abnormal_autophagy | 1.38327327 |
| 65 | MP0003300_gastrointestinal_ulcer | 1.37880163 |
| 66 | MP0003567_abnormal_fetal_cardiomyocyte | 1.37104596 |
| 67 | MP0003195_calcinosis | 1.30875921 |
| 68 | MP0005464_abnormal_platelet_physiology | 1.30767006 |
| 69 | MP0005666_abnormal_adipose_tissue | 1.27474913 |
| 70 | MP0002332_abnormal_exercise_endurance | 1.26098296 |
| 71 | MP0010329_abnormal_lipoprotein_level | 1.24529734 |
| 72 | MP0002234_abnormal_pharynx_morphology | 1.22436098 |
| 73 | MP0005165_increased_susceptibility_to | 1.21800617 |
| 74 | MP0000604_amyloidosis | 1.20756918 |
| 75 | MP0000343_altered_response_to | 1.20501839 |
| 76 | MP0010368_abnormal_lymphatic_system | 1.20092504 |
| 77 | MP0005025_abnormal_response_to | 1.19392637 |
| 78 | MP0003879_abnormal_hair_cell | 1.17535707 |
| 79 | MP0000266_abnormal_heart_morphology | 1.17316204 |
| 80 | MP0003279_aneurysm | 1.15281707 |
| 81 | MP0010155_abnormal_intestine_physiology | 1.15250803 |
| 82 | MP0005670_abnormal_white_adipose | 1.13980913 |
| 83 | MP0002998_abnormal_bone_remodeling | 1.12366419 |
| 84 | MP0005171_absent_coat_pigmentation | 1.08169524 |
| 85 | MP0002405_respiratory_system_inflammati | 1.06391429 |
| 86 | MP0004947_skin_inflammation | 1.06149199 |
| 87 | MP0005387_immune_system_phenotype | 1.04634680 |
| 88 | MP0001790_abnormal_immune_system | 1.04634680 |
| 89 | MP0002877_abnormal_melanocyte_morpholog | 1.01823545 |
| 90 | MP0006035_abnormal_mitochondrial_morpho | 1.01600666 |
| 91 | MP0005000_abnormal_immune_tolerance | 0.99679931 |
| 92 | MP0000609_abnormal_liver_physiology | 0.99562717 |
| 93 | MP0005023_abnormal_wound_healing | 0.99373361 |
| 94 | MP0002398_abnormal_bone_marrow | 0.96329169 |
| 95 | MP0003075_altered_response_to | 0.94774591 |
| 96 | MP0008004_abnormal_stomach_pH | 0.94222626 |
| 97 | MP0001958_emphysema | 0.94063399 |
| 98 | MP0002420_abnormal_adaptive_immunity | 0.93143896 |
| 99 | MP0001542_abnormal_bone_strength | 0.93111692 |
| 100 | MP0005623_abnormal_meninges_morphology | 0.92309883 |
| 101 | MP0003763_abnormal_thymus_physiology | 0.91563223 |
| 102 | MP0000858_altered_metastatic_potential | 0.91519694 |
| 103 | MP0001915_intracranial_hemorrhage | 0.90388489 |
| 104 | MP0001819_abnormal_immune_cell | 0.89893583 |
| 105 | MP0003283_abnormal_digestive_organ | 0.89085204 |
| 106 | MP0009764_decreased_sensitivity_to | 0.88113491 |
| 107 | MP0000716_abnormal_immune_system | 0.87595815 |
| 108 | MP0000230_abnormal_systemic_arterial | 0.87275096 |
| 109 | MP0002722_abnormal_immune_system | 0.86417368 |
| 110 | MP0008469_abnormal_protein_level | 0.85795987 |
| 111 | MP0003329_amyloid_beta_deposits | 0.85337292 |
| 112 | MP0002060_abnormal_skin_morphology | 0.83376121 |
| 113 | MP0001853_heart_inflammation | 0.83190348 |
| 114 | MP0001800_abnormal_humoral_immune | 0.82260751 |
| 115 | MP0009765_abnormal_xenobiotic_induced | 0.82099434 |
| 116 | MP0002723_abnormal_immune_serum | 0.82027387 |
| 117 | MP0002128_abnormal_blood_circulation | 0.81621003 |
| 118 | MP0000015_abnormal_ear_pigmentation | 0.81181637 |
| 119 | MP0005375_adipose_tissue_phenotype | 0.80745725 |
| 120 | MP0002452_abnormal_antigen_presenting | 0.80383440 |
| 121 | MP0001661_extended_life_span | 0.80368547 |
| 122 | MP0002166_altered_tumor_susceptibility | 0.80051994 |
| 123 | MP0009333_abnormal_splenocyte_physiolog | 0.79018686 |
| 124 | MP0005164_abnormal_response_to | 0.78646073 |
| 125 | MP0003453_abnormal_keratinocyte_physiol | 0.78610245 |
| 126 | MP0002909_abnormal_adrenal_gland | 0.78179416 |
| 127 | MP0004185_abnormal_adipocyte_glucose | 0.78010836 |
| 128 | MP0002933_joint_inflammation | 0.77279958 |
| 129 | MP0000703_abnormal_thymus_morphology | 0.76947489 |
| 130 | MP0005166_decreased_susceptibility_to | 0.76592843 |
| 131 | MP0001533_abnormal_skeleton_physiology | 0.76398073 |
| 132 | MP0000465_gastrointestinal_hemorrhage | 0.76090163 |
| 133 | MP0002249_abnormal_larynx_morphology | 0.75436796 |
| 134 | MP0002429_abnormal_blood_cell | 0.75072205 |
| 135 | MP0005266_abnormal_metabolism | 0.72107406 |
| 136 | MP0003566_abnormal_cell_adhesion | 0.69876725 |
| 137 | MP0004147_increased_porphyrin_level | 0.68361601 |
| 138 | MP0005451_abnormal_body_composition | 0.62411083 |
| 139 | MP0001879_abnormal_lymphatic_vessel | 0.61087224 |
| 140 | MP0002108_abnormal_muscle_morphology | 0.60785456 |
| 141 | MP0004043_abnormal_pH_regulation | 0.59303332 |
| 142 | MP0000767_abnormal_smooth_muscle | 0.55329402 |
| 143 | MP0004272_abnormal_basement_membrane | 0.54780244 |
| 144 | MP0005187_abnormal_penis_morphology | 0.52483217 |
| 145 | MP0005386_behavior/neurological_phenoty | 0.47216222 |
| 146 | MP0004924_abnormal_behavior | 0.47216222 |
| 147 | MP0004859_abnormal_synaptic_plasticity | 0.45254764 |
| 148 | MP0002925_abnormal_cardiovascular_devel | 0.45092392 |
| 149 | MP0005319_abnormal_enzyme/_coenzyme | 0.43869551 |
| 150 | MP0005535_abnormal_body_temperature | 0.42128554 |
| 151 | MP0000013_abnormal_adipose_tissue | 0.41869732 |
| 152 | MP0002822_catalepsy | 0.41842396 |
| 153 | MP0002078_abnormal_glucose_homeostasis | 0.41430712 |
| 154 | MP0000003_abnormal_adipose_tissue | 0.40627525 |
| 155 | MP0009384_cardiac_valve_regurgitation | 0.39419478 |
| 156 | MP0005595_abnormal_vascular_smooth | 0.39392459 |
| 157 | MP0001784_abnormal_fluid_regulation | 0.38684172 |
| 158 | MP0003806_abnormal_nucleotide_metabolis | 0.38109239 |
| 159 | MP0005167_abnormal_blood-brain_barrier | 0.37692829 |
| 160 | MP0003878_abnormal_ear_physiology | 0.37548623 |
| 161 | MP0005377_hearing/vestibular/ear_phenot | 0.37548623 |
| 162 | MP0003705_abnormal_hypodermis_morpholog | 0.36800552 |
| 163 | MP0003984_embryonic_growth_retardation | 0.35439679 |
| 164 | MP0008961_abnormal_basal_metabolism | 0.35405584 |
| 165 | MP0002088_abnormal_embryonic_growth/wei | 0.34111741 |
| 166 | MP0001614_abnormal_blood_vessel | 0.33606901 |
| 167 | MP0002971_abnormal_brown_adipose | 0.31580886 |
| 168 | MP0000733_abnormal_muscle_development | 0.30712531 |
| 169 | MP0009780_abnormal_chondrocyte_physiolo | 0.30453975 |
| 170 | MP0003948_abnormal_gas_homeostasis | 0.30083784 |
| 171 | MP0002735_abnormal_chemical_nociception | 0.29259082 |
| 172 | MP0008874_decreased_physiological_sensi | 0.28727356 |
| 173 | MP0001727_abnormal_embryo_implantation | 0.28183001 |
| 174 | MP0008569_lethality_at_weaning | 0.27804417 |
| 175 | MP0002295_abnormal_pulmonary_circulatio | 0.26158984 |
| 176 | MP0008438_abnormal_cutaneous_collagen | 0.24579164 |
| 177 | MP0003656_abnormal_erythrocyte_physiolo | 0.22193090 |
| 178 | MP0002272_abnormal_nervous_system | 0.20067690 |
| 179 | MP0005388_respiratory_system_phenotype | 0.19610727 |
| 180 | MP0002133_abnormal_respiratory_system | 0.19610727 |
| 181 | MP0001485_abnormal_pinna_reflex | 0.19575033 |
| 182 | MP0003635_abnormal_synaptic_transmissio | 0.18453658 |
| 183 | MP0000249_abnormal_blood_vessel | 0.18220953 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 8.72123477 |
| 2 | Ventricular tachycardia (HP:0004756) | 7.20877297 |
| 3 | Atrial fibrillation (HP:0005110) | 6.63664680 |
| 4 | Primary atrial arrhythmia (HP:0001692) | 6.24329619 |
| 5 | Supraventricular tachycardia (HP:0004755) | 6.05278021 |
| 6 | Calf muscle hypertrophy (HP:0008981) | 5.94736621 |
| 7 | Supraventricular arrhythmia (HP:0005115) | 5.93717337 |
| 8 | Syncope (HP:0001279) | 5.56394234 |
| 9 | Lipoatrophy (HP:0100578) | 5.52944127 |
| 10 | Subaortic stenosis (HP:0001682) | 5.48008097 |
| 11 | Abnormality of the left ventricular outflow tract (HP:0011103) | 5.48008097 |
| 12 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.32771226 |
| 13 | Muscle fiber splitting (HP:0003555) | 5.25612977 |
| 14 | Abnormality of the calf musculature (HP:0001430) | 5.14204420 |
| 15 | Exercise-induced muscle cramps (HP:0003710) | 5.11873315 |
| 16 | Exercise-induced myalgia (HP:0003738) | 5.06481746 |
| 17 | Right ventricular cardiomyopathy (HP:0011663) | 5.03071946 |
| 18 | Prolonged QT interval (HP:0001657) | 4.93353992 |
| 19 | Bundle branch block (HP:0011710) | 4.92247199 |
| 20 | Palpitations (HP:0001962) | 4.83821696 |
| 21 | Dilated cardiomyopathy (HP:0001644) | 4.55402328 |
| 22 | Ventricular fibrillation (HP:0001663) | 4.54915157 |
| 23 | Deep venous thrombosis (HP:0002625) | 4.54231272 |
| 24 | Hyporeflexia of lower limbs (HP:0002600) | 4.53012365 |
| 25 | Ventricular arrhythmia (HP:0004308) | 4.48545994 |
| 26 | Myoglobinuria (HP:0002913) | 4.37620984 |
| 27 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.22659841 |
| 28 | Asymmetric septal hypertrophy (HP:0001670) | 4.13248756 |
| 29 | Heart block (HP:0012722) | 4.04524714 |
| 30 | Atrioventricular block (HP:0001678) | 3.97808177 |
| 31 | EMG: myopathic abnormalities (HP:0003458) | 3.83841067 |
| 32 | Abnormal atrioventricular conduction (HP:0005150) | 3.79584347 |
| 33 | Abnormal EKG (HP:0003115) | 3.68972117 |
| 34 | Complement deficiency (HP:0004431) | 3.54468764 |
| 35 | Joint hemorrhage (HP:0005261) | 3.52425627 |
| 36 | Abnormality of complement system (HP:0005339) | 3.50166036 |
| 37 | Increased connective tissue (HP:0009025) | 3.41854195 |
| 38 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.28241685 |
| 39 | Myotonia (HP:0002486) | 3.25660732 |
| 40 | Acute necrotizing encephalopathy (HP:0006965) | 3.25435213 |
| 41 | Rhabdomyolysis (HP:0003201) | 3.24983186 |
| 42 | Left ventricular hypertrophy (HP:0001712) | 3.21064994 |
| 43 | Hepatic necrosis (HP:0002605) | 3.20604951 |
| 44 | Abnormality of the fingertips (HP:0001211) | 3.10877217 |
| 45 | Axonal loss (HP:0003447) | 3.08963626 |
| 46 | Hemorrhage of the eye (HP:0011885) | 2.93216988 |
| 47 | Hepatocellular necrosis (HP:0001404) | 2.91431920 |
| 48 | Systemic lupus erythematosus (HP:0002725) | 2.91073047 |
| 49 | Difficulty running (HP:0009046) | 2.90898074 |
| 50 | Ketoacidosis (HP:0001993) | 2.76101704 |
| 51 | Acute encephalopathy (HP:0006846) | 2.75977836 |
| 52 | Mitochondrial inheritance (HP:0001427) | 2.74591177 |
| 53 | Ragged-red muscle fibers (HP:0003200) | 2.74116382 |
| 54 | Palmoplantar keratoderma (HP:0000982) | 2.73996952 |
| 55 | Difficulty climbing stairs (HP:0003551) | 2.72429403 |
| 56 | Progressive macrocephaly (HP:0004481) | 2.70056462 |
| 57 | Hyperlipoproteinemia (HP:0010980) | 2.68196385 |
| 58 | Mitral stenosis (HP:0001718) | 2.65030685 |
| 59 | Testicular atrophy (HP:0000029) | 2.56788551 |
| 60 | Prolonged partial thromboplastin time (HP:0003645) | 2.55834799 |
| 61 | Increased muscle lipid content (HP:0009058) | 2.55137768 |
| 62 | Increased CSF lactate (HP:0002490) | 2.54380837 |
| 63 | Ulnar bowing (HP:0003031) | 2.54341076 |
| 64 | Protrusio acetabuli (HP:0003179) | 2.54119552 |
| 65 | Hypoalphalipoproteinemia (HP:0003233) | 2.53468482 |
| 66 | Glomerulonephritis (HP:0000099) | 2.48765583 |
| 67 | Colitis (HP:0002583) | 2.46058895 |
| 68 | Hypoglycemic coma (HP:0001325) | 2.45421313 |
| 69 | Cerebral edema (HP:0002181) | 2.44396129 |
| 70 | Hypertriglyceridemia (HP:0002155) | 2.43321248 |
| 71 | Cerebral aneurysm (HP:0004944) | 2.41344005 |
| 72 | Conjunctival hamartoma (HP:0100780) | 2.40838595 |
| 73 | Cellulitis (HP:0100658) | 2.40314728 |
| 74 | Dysostosis multiplex (HP:0000943) | 2.38447050 |
| 75 | Sudden cardiac death (HP:0001645) | 2.37739504 |
| 76 | Asymmetry of the thorax (HP:0001555) | 2.36501502 |
| 77 | Abnormal platelet function (HP:0011869) | 2.35047251 |
| 78 | Impaired platelet aggregation (HP:0003540) | 2.35047251 |
| 79 | Pheochromocytoma (HP:0002666) | 2.33541501 |
| 80 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.33280801 |
| 81 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.33252001 |
| 82 | Dicarboxylic aciduria (HP:0003215) | 2.33252001 |
| 83 | Double outlet right ventricle (HP:0001719) | 2.30690115 |
| 84 | Congenital malformation of the right heart (HP:0011723) | 2.30690115 |
| 85 | Limb-girdle muscle atrophy (HP:0003797) | 2.29427506 |
| 86 | Increased intramyocellular lipid droplets (HP:0012240) | 2.28868331 |
| 87 | Acute lymphatic leukemia (HP:0006721) | 2.28190987 |
| 88 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.27179656 |
| 89 | Lactic acidosis (HP:0003128) | 2.26995779 |
| 90 | Polygenic inheritance (HP:0010982) | 2.25643167 |
| 91 | Respiratory failure (HP:0002878) | 2.22932090 |
| 92 | Distal lower limb muscle weakness (HP:0009053) | 2.22331590 |
| 93 | Exercise intolerance (HP:0003546) | 2.20403080 |
| 94 | Aortic regurgitation (HP:0001659) | 2.20306060 |
| 95 | Mediastinal lymphadenopathy (HP:0100721) | 2.19432079 |
| 96 | Joint stiffness (HP:0001387) | 2.16200523 |
| 97 | Increased variability in muscle fiber diameter (HP:0003557) | 2.15794214 |
| 98 | Syringomyelia (HP:0003396) | 2.15652285 |
| 99 | Spinal cord lesions (HP:0100561) | 2.15652285 |
| 100 | Increased serum ferritin (HP:0003281) | 2.15172197 |
| 101 | Xanthomatosis (HP:0000991) | 2.14184388 |
| 102 | Thin bony cortex (HP:0002753) | 2.12821054 |
| 103 | Neuroendocrine neoplasm (HP:0100634) | 2.12704536 |
| 104 | Areflexia of lower limbs (HP:0002522) | 2.10042834 |
| 105 | Abnormality of the Achilles tendon (HP:0005109) | 2.09839101 |
| 106 | Myocardial infarction (HP:0001658) | 2.09122579 |
| 107 | Abnormality of the peritoneum (HP:0002585) | 2.08158269 |
| 108 | Congestive heart failure (HP:0001635) | 2.06909753 |
| 109 | Premature rupture of membranes (HP:0001788) | 2.06400170 |
| 110 | Dysmetric saccades (HP:0000641) | 2.05303751 |
| 111 | Obstructive sleep apnea (HP:0002870) | 2.05231738 |
| 112 | Abnormality of the foot musculature (HP:0001436) | 2.03971298 |
| 113 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.02891679 |
| 114 | Abnormality of alanine metabolism (HP:0010916) | 2.02891679 |
| 115 | Hyperalaninemia (HP:0003348) | 2.02891679 |
| 116 | Reticulocytosis (HP:0001923) | 2.01726497 |
| 117 | Stroke (HP:0001297) | 2.00968802 |
| 118 | Neoplasm of the adrenal gland (HP:0100631) | 2.00595890 |
| 119 | Muscle stiffness (HP:0003552) | 2.00241656 |
| 120 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.00008329 |
| 121 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.00008329 |
| 122 | Abnormality of glycolipid metabolism (HP:0010969) | 2.00008329 |
| 123 | Hamartoma of the eye (HP:0010568) | 1.99807398 |
| 124 | Ketosis (HP:0001946) | 1.99482297 |
| 125 | Aortic aneurysm (HP:0004942) | 1.97072342 |
| 126 | Blue sclerae (HP:0000592) | 1.96969383 |
| 127 | Hypoplastic left heart (HP:0004383) | 1.96697553 |
| 128 | Spondylolisthesis (HP:0003302) | 1.96471819 |
| 129 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.96127164 |
| 130 | Neoplasm of head and neck (HP:0012288) | 1.95293611 |
| 131 | Esophageal neoplasm (HP:0100751) | 1.95293611 |
| 132 | Menorrhagia (HP:0000132) | 1.94589471 |
| 133 | Neck muscle weakness (HP:0000467) | 1.94156938 |
| 134 | Disproportionate tall stature (HP:0001519) | 1.93801401 |
| 135 | Large for gestational age (HP:0001520) | 1.93206761 |
| 136 | Achilles tendon contracture (HP:0001771) | 1.92463589 |
| 137 | Aneurysm (HP:0002617) | 1.91135990 |
| 138 | Fragile skin (HP:0001030) | 1.90629321 |
| 139 | Ectopia lentis (HP:0001083) | 1.90551492 |
| 140 | Emphysema (HP:0002097) | 1.90450898 |
| 141 | Lymphangioma (HP:0100764) | 1.87950980 |
| 142 | Pulmonary artery stenosis (HP:0004415) | 1.87894867 |
| 143 | EMG: neuropathic changes (HP:0003445) | 1.86589460 |
| 144 | Lipid accumulation in hepatocytes (HP:0006561) | 1.85301787 |
| 145 | Gingivitis (HP:0000230) | 1.85225664 |
| 146 | Nephritis (HP:0000123) | 1.84915961 |
| 147 | Dilatation of the ascending aorta (HP:0005111) | 1.84287154 |
| 148 | Bone pain (HP:0002653) | 1.83958396 |
| 149 | Distal lower limb amyotrophy (HP:0008944) | 1.82599683 |
| 150 | Foot dorsiflexor weakness (HP:0009027) | 1.82500289 |
| 151 | Genu recurvatum (HP:0002816) | 1.82341417 |
| 152 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.82100677 |
| 153 | Broad face (HP:0000283) | 1.81472443 |
| 154 | Abnormality of the thoracic spine (HP:0100711) | 1.81263486 |
| 155 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.80369551 |
| 156 | Peritonitis (HP:0002586) | 1.80070278 |
| 157 | Epistaxis (HP:0000421) | 1.79866189 |
| 158 | Polycythemia (HP:0001901) | 1.78891655 |
| 159 | Athetosis (HP:0002305) | 1.78838126 |
| 160 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.77722303 |
| 161 | Mucopolysacchariduria (HP:0008155) | 1.77722303 |
| 162 | Hypochromic anemia (HP:0001931) | 1.77057865 |
| 163 | Pathologic fracture (HP:0002756) | 1.76718667 |
| 164 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.76617839 |
| 165 | Tinnitus (HP:0000360) | 1.74896683 |
| 166 | Anteriorly placed anus (HP:0001545) | 1.74644711 |
| 167 | Central scotoma (HP:0000603) | 1.74609419 |
| 168 | Elbow flexion contracture (HP:0002987) | 1.74447904 |
| 169 | Abnormality of the anterior chamber (HP:0000593) | 1.74152446 |
| 170 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.73582787 |
| 171 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.73241907 |
| 172 | Meningitis (HP:0001287) | 1.72508819 |
| 173 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.71565244 |
| 174 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.71565244 |
| 175 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.71565244 |
| 176 | Flared iliac wings (HP:0002869) | 1.70753596 |
| 177 | Annular pancreas (HP:0001734) | 1.70574638 |
| 178 | Muscular dystrophy (HP:0003560) | 1.69982324 |
| 179 | Hypobetalipoproteinemia (HP:0003563) | 1.69886099 |
| 180 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.68959027 |
| 181 | Venous abnormality (HP:0002624) | 1.68745259 |
| 182 | Thin ribs (HP:0000883) | 1.68564181 |
| 183 | Agammaglobulinemia (HP:0004432) | 1.68271751 |
| 184 | Gowers sign (HP:0003391) | 1.68157178 |
| 185 | Myositis (HP:0100614) | 1.67809308 |
| 186 | Abnormality of the tricuspid valve (HP:0001702) | 1.66980483 |
| 187 | Bowed forearm bones (HP:0003956) | 1.66425500 |
| 188 | Bowing of the arm (HP:0006488) | 1.66425500 |
| 189 | Mitral valve prolapse (HP:0001634) | 1.65710001 |
| 190 | Gastrointestinal inflammation (HP:0004386) | 1.65693936 |
| 191 | Premature skin wrinkling (HP:0100678) | 1.65571443 |
| 192 | Stridor (HP:0010307) | 1.63521446 |
| 193 | Type 1 muscle fiber predominance (HP:0003803) | 1.63357970 |
| 194 | Abnormality of iron homeostasis (HP:0011031) | 1.62752555 |
| 195 | Multiple lipomas (HP:0001012) | 1.62407222 |
| 196 | Broad metatarsal (HP:0001783) | 1.60825263 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 5.34423668 |
| 2 | LMTK2 | 4.38445035 |
| 3 | MYLK | 4.31700017 |
| 4 | PHKG2 | 3.98036024 |
| 5 | PHKG1 | 3.98036024 |
| 6 | PRPF4B | 3.86867137 |
| 7 | ERN1 | 3.64454787 |
| 8 | PKN2 | 3.53381237 |
| 9 | PDK4 | 3.28613515 |
| 10 | PDK3 | 3.28613515 |
| 11 | DMPK | 3.27955537 |
| 12 | TRIB3 | 2.87128772 |
| 13 | OBSCN | 2.80638528 |
| 14 | CDK12 | 2.51195628 |
| 15 | MAP3K13 | 2.45326695 |
| 16 | STK24 | 2.40207784 |
| 17 | MUSK | 2.38184608 |
| 18 | BCKDK | 2.30994970 |
| 19 | TIE1 | 2.25210475 |
| 20 | NEK1 | 2.22100660 |
| 21 | PIK3CA | 2.12737305 |
| 22 | MAP4K1 | 2.01050994 |
| 23 | MAP3K6 | 1.99143630 |
| 24 | EEF2K | 1.99142307 |
| 25 | PINK1 | 1.92315273 |
| 26 | SIK1 | 1.90917301 |
| 27 | KIT | 1.87689229 |
| 28 | PRKD2 | 1.85861666 |
| 29 | PDK2 | 1.84915213 |
| 30 | TAOK2 | 1.84620681 |
| 31 | SMG1 | 1.80046343 |
| 32 | PAK3 | 1.72373537 |
| 33 | BLK | 1.68732978 |
| 34 | GRK7 | 1.66023150 |
| 35 | CAMK2D | 1.51916585 |
| 36 | ILK | 1.46368930 |
| 37 | PRKD1 | 1.45284307 |
| 38 | TNK2 | 1.40834911 |
| 39 | IRAK3 | 1.34972194 |
| 40 | FES | 1.29710455 |
| 41 | TBK1 | 1.28827790 |
| 42 | IRAK2 | 1.25430315 |
| 43 | CDC42BPA | 1.25316587 |
| 44 | GRK6 | 1.23328553 |
| 45 | MAP3K14 | 1.23312779 |
| 46 | WNK4 | 1.17306526 |
| 47 | MAP2K6 | 1.17098353 |
| 48 | ZAP70 | 1.16398466 |
| 49 | MAP3K11 | 1.12880771 |
| 50 | CSF1R | 1.09587109 |
| 51 | SIK2 | 1.09089729 |
| 52 | DAPK3 | 1.07827624 |
| 53 | ROCK1 | 1.06881388 |
| 54 | MAP3K7 | 1.04808089 |
| 55 | CDK8 | 1.01673907 |
| 56 | MAPK12 | 0.99245349 |
| 57 | PTK2B | 0.98798149 |
| 58 | STK4 | 0.95672315 |
| 59 | MAPKAPK3 | 0.94450862 |
| 60 | CAMK4 | 0.93673713 |
| 61 | MARK2 | 0.92238311 |
| 62 | TAOK1 | 0.91743889 |
| 63 | RIPK1 | 0.91349213 |
| 64 | MAP3K5 | 0.90917146 |
| 65 | ABL2 | 0.88267703 |
| 66 | IRAK4 | 0.87872062 |
| 67 | FLT3 | 0.87182007 |
| 68 | CAMK2A | 0.86497144 |
| 69 | STK38 | 0.86451966 |
| 70 | CAMK1 | 0.84637889 |
| 71 | STK38L | 0.79683805 |
| 72 | PRKAA1 | 0.78794042 |
| 73 | CAMK1D | 0.77215572 |
| 74 | CHUK | 0.74490495 |
| 75 | PRKAA2 | 0.74256158 |
| 76 | ROCK2 | 0.73344328 |
| 77 | PKN1 | 0.73051746 |
| 78 | IKBKE | 0.72740714 |
| 79 | KDR | 0.72620469 |
| 80 | RIPK4 | 0.71730746 |
| 81 | BTK | 0.71554689 |
| 82 | RAF1 | 0.70461089 |
| 83 | MAPK4 | 0.69564228 |
| 84 | HIPK2 | 0.69403622 |
| 85 | PRKD3 | 0.69334045 |
| 86 | RPS6KC1 | 0.69024559 |
| 87 | RPS6KL1 | 0.69024559 |
| 88 | MAPK15 | 0.68638707 |
| 89 | FGFR4 | 0.68001967 |
| 90 | INSRR | 0.65628707 |
| 91 | CDK6 | 0.65584591 |
| 92 | ZAK | 0.64351072 |
| 93 | PDGFRA | 0.64131473 |
| 94 | TRPM7 | 0.63995729 |
| 95 | IRAK1 | 0.63683638 |
| 96 | PRKCE | 0.60802487 |
| 97 | CDK7 | 0.60615874 |
| 98 | NEK9 | 0.60395366 |
| 99 | MAP3K4 | 0.59554944 |
| 100 | RPS6KA6 | 0.57773887 |
| 101 | PIM2 | 0.57417928 |
| 102 | MOS | 0.56696668 |
| 103 | WNK1 | 0.55392661 |
| 104 | PAK2 | 0.54946254 |
| 105 | STK39 | 0.54186535 |
| 106 | PRKACB | 0.54101934 |
| 107 | CDK4 | 0.51717144 |
| 108 | PDPK1 | 0.50308983 |
| 109 | PIK3CG | 0.50251588 |
| 110 | CSK | 0.49183347 |
| 111 | ARAF | 0.49177921 |
| 112 | DDR2 | 0.47056724 |
| 113 | PRKACA | 0.46240799 |
| 114 | HCK | 0.45695116 |
| 115 | NTRK1 | 0.45680327 |
| 116 | PDK1 | 0.45545795 |
| 117 | TGFBR2 | 0.45405836 |
| 118 | SYK | 0.45263679 |
| 119 | IKBKB | 0.45242962 |
| 120 | PRKACG | 0.44677142 |
| 121 | EPHB1 | 0.43887111 |
| 122 | ICK | 0.43841867 |
| 123 | NME2 | 0.43397094 |
| 124 | CAMK2G | 0.41114180 |
| 125 | PDGFRB | 0.40814939 |
| 126 | JAK3 | 0.40731308 |
| 127 | RET | 0.38888705 |
| 128 | BMX | 0.38688638 |
| 129 | FER | 0.38369081 |
| 130 | LYN | 0.37378719 |
| 131 | MAP3K8 | 0.35252833 |
| 132 | JAK2 | 0.34917207 |
| 133 | PAK6 | 0.34849732 |
| 134 | DYRK1B | 0.34679712 |
| 135 | MAPK3 | 0.34623475 |
| 136 | MAP2K1 | 0.34454435 |
| 137 | PRKCH | 0.34053881 |
| 138 | MAP3K3 | 0.32925224 |
| 139 | MAPK10 | 0.32853697 |
| 140 | MAP2K3 | 0.29737172 |
| 141 | NTRK3 | 0.28991777 |
| 142 | NME1 | 0.28709526 |
| 143 | KSR2 | 0.28517073 |
| 144 | PTK6 | 0.25922209 |
| 145 | RPS6KA1 | 0.25830545 |
| 146 | RPS6KA2 | 0.25549318 |
| 147 | AKT2 | 0.24834078 |
| 148 | MAP3K1 | 0.22734764 |
| 149 | LATS2 | 0.21755905 |
| 150 | EPHA4 | 0.20565778 |
| 151 | SGK3 | 0.20076612 |
| 152 | MAP2K4 | 0.19944953 |
| 153 | PRKG2 | 0.18724113 |
| 154 | CAMK2B | 0.18322096 |
| 155 | UHMK1 | 0.17969266 |
| 156 | RPS6KA3 | 0.17070389 |
| 157 | SGK1 | 0.16909943 |
| 158 | PRKG1 | 0.15366683 |
| 159 | EPHB2 | 0.14019103 |
| 160 | PRKCQ | 0.12993848 |
| 161 | JAK1 | 0.12093553 |
| 162 | MTOR | 0.11952356 |
| 163 | MAP3K10 | 0.10265804 |
| 164 | CAMKK1 | 0.10229702 |
| 165 | GRK5 | 0.09877870 |
| 166 | MAPK11 | 0.09364912 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.75150087 |
| 2 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.58078175 |
| 3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 4.12341327 |
| 4 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.75557453 |
| 5 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.52689616 |
| 6 | Parkinsons disease_Homo sapiens_hsa05012 | 3.46416919 |
| 7 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.38192329 |
| 8 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.15287575 |
| 9 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 3.08168341 |
| 10 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.91648524 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.66009577 |
| 12 | Sulfur relay system_Homo sapiens_hsa04122 | 2.64210851 |
| 13 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.63176909 |
| 14 | Alzheimers disease_Homo sapiens_hsa05010 | 2.60570484 |
| 15 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.30595501 |
| 16 | Carbon metabolism_Homo sapiens_hsa01200 | 2.28923930 |
| 17 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 2.27251286 |
| 18 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.23533358 |
| 19 | Huntingtons disease_Homo sapiens_hsa05016 | 2.21402335 |
| 20 | Other glycan degradation_Homo sapiens_hsa00511 | 2.10756957 |
| 21 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 2.02824539 |
| 22 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.99529489 |
| 23 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.92890059 |
| 24 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.91482601 |
| 25 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.69265402 |
| 26 | Viral myocarditis_Homo sapiens_hsa05416 | 1.61535515 |
| 27 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.54813365 |
| 28 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.54499323 |
| 29 | Prion diseases_Homo sapiens_hsa05020 | 1.53237930 |
| 30 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.42283359 |
| 31 | Leishmaniasis_Homo sapiens_hsa05140 | 1.36929156 |
| 32 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.33536876 |
| 33 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.31041759 |
| 34 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.28605253 |
| 35 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.25863559 |
| 36 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.18191307 |
| 37 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.18060790 |
| 38 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.17472571 |
| 39 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.12151304 |
| 40 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.09923106 |
| 41 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.09717159 |
| 42 | Alcoholism_Homo sapiens_hsa05034 | 1.09382595 |
| 43 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.05249354 |
| 44 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.02571450 |
| 45 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.01238244 |
| 46 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.00987918 |
| 47 | Pertussis_Homo sapiens_hsa05133 | 0.99942588 |
| 48 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.98812690 |
| 49 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.98137112 |
| 50 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.97917527 |
| 51 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.97318352 |
| 52 | ABC transporters_Homo sapiens_hsa02010 | 0.96242135 |
| 53 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.95207339 |
| 54 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.94662738 |
| 55 | Malaria_Homo sapiens_hsa05144 | 0.91538359 |
| 56 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.90963128 |
| 57 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.89526325 |
| 58 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.89386222 |
| 59 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.89332708 |
| 60 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.89241649 |
| 61 | Insulin resistance_Homo sapiens_hsa04931 | 0.89024405 |
| 62 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.88604461 |
| 63 | Influenza A_Homo sapiens_hsa05164 | 0.86743312 |
| 64 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.84931495 |
| 65 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.83311525 |
| 66 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.82748776 |
| 67 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.81984473 |
| 68 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.81698586 |
| 69 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.80729380 |
| 70 | Glioma_Homo sapiens_hsa05214 | 0.79491206 |
| 71 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.78594449 |
| 72 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.77588375 |
| 73 | Circadian entrainment_Homo sapiens_hsa04713 | 0.76772713 |
| 74 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.76665657 |
| 75 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.76493396 |
| 76 | Tuberculosis_Homo sapiens_hsa05152 | 0.75989901 |
| 77 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.75801179 |
| 78 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.73919373 |
| 79 | Renin secretion_Homo sapiens_hsa04924 | 0.73650108 |
| 80 | Hepatitis C_Homo sapiens_hsa05160 | 0.73056666 |
| 81 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.71409646 |
| 82 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.70167314 |
| 83 | Bladder cancer_Homo sapiens_hsa05219 | 0.69872044 |
| 84 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.69020341 |
| 85 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.68842527 |
| 86 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.68589724 |
| 87 | Hepatitis B_Homo sapiens_hsa05161 | 0.68091195 |
| 88 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.68085443 |
| 89 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.67891287 |
| 90 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.67770729 |
| 91 | Insulin secretion_Homo sapiens_hsa04911 | 0.67240259 |
| 92 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.67081483 |
| 93 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.66936434 |
| 94 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.66280956 |
| 95 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.65011389 |
| 96 | Lysine degradation_Homo sapiens_hsa00310 | 0.63823960 |
| 97 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.63193475 |
| 98 | Focal adhesion_Homo sapiens_hsa04510 | 0.61524775 |
| 99 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.61154187 |
| 100 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.60041016 |
| 101 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.59732675 |
| 102 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.58565707 |
| 103 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.57038779 |
| 104 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.55872442 |
| 105 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.55845031 |
| 106 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.55605718 |
| 107 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.54999307 |
| 108 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.54967968 |
| 109 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.54363785 |
| 110 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.54159636 |
| 111 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.52457032 |
| 112 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.51858709 |
| 113 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.51841644 |
| 114 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.51783845 |
| 115 | Apoptosis_Homo sapiens_hsa04210 | 0.49920272 |
| 116 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.49452700 |
| 117 | Olfactory transduction_Homo sapiens_hsa04740 | 0.48281539 |
| 118 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.48065790 |
| 119 | Taste transduction_Homo sapiens_hsa04742 | 0.46081923 |
| 120 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.45510914 |
| 121 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.45080133 |
| 122 | HTLV-I infection_Homo sapiens_hsa05166 | 0.44595370 |
| 123 | Prostate cancer_Homo sapiens_hsa05215 | 0.44524794 |
| 124 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.44299461 |
| 125 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.44097899 |
| 126 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.43263169 |
| 127 | Lysosome_Homo sapiens_hsa04142 | 0.43031346 |
| 128 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.43019513 |
| 129 | Galactose metabolism_Homo sapiens_hsa00052 | 0.40562168 |
| 130 | Long-term potentiation_Homo sapiens_hsa04720 | 0.39941580 |
| 131 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.38619056 |
| 132 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.38381932 |
| 133 | Salivary secretion_Homo sapiens_hsa04970 | 0.38213019 |
| 134 | Tight junction_Homo sapiens_hsa04530 | 0.37419899 |
| 135 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.36114597 |
| 136 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.36033233 |
| 137 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.35192253 |
| 138 | Morphine addiction_Homo sapiens_hsa05032 | 0.34810570 |
| 139 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.33939966 |
| 140 | Peroxisome_Homo sapiens_hsa04146 | 0.32886264 |
| 141 | Gap junction_Homo sapiens_hsa04540 | 0.32467127 |
| 142 | Amoebiasis_Homo sapiens_hsa05146 | 0.30362520 |
| 143 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.29690450 |
| 144 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.29012495 |
| 145 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.27745471 |
| 146 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.27465237 |
| 147 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.27060018 |
| 148 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.26013816 |
| 149 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.23286631 |
| 150 | GABAergic synapse_Homo sapiens_hsa04727 | 0.23005023 |
| 151 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.22696283 |
| 152 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.21213080 |
| 153 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.20726190 |
| 154 | Metabolic pathways_Homo sapiens_hsa01100 | 0.20566617 |
| 155 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.20550288 |
| 156 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.18112547 |
| 157 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.17441135 |
| 158 | Adherens junction_Homo sapiens_hsa04520 | 0.16611584 |
| 159 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.16352178 |
| 160 | Bile secretion_Homo sapiens_hsa04976 | 0.15751579 |
| 161 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.14988005 |
| 162 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.14936633 |
| 163 | Circadian rhythm_Homo sapiens_hsa04710 | 0.13394003 |
| 164 | Platelet activation_Homo sapiens_hsa04611 | 0.13301188 |
| 165 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.11014352 |
| 166 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.10753374 |
| 167 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.10201975 |

